May 26, 2011 – Cinterion, a cellular machine-to-machine (M2M) communication modules company, and TZ Medical, a manufacturer of critical-care medical products, announced Aera-CT, a lightweight and cost effective mHealth heart arrhythmia monitoring device (a Holter monitor). Equipped with the Cinterion MC75i module, the Aera-CT is expected to be commercially available in North America in Q3, 2011, followed by rolling launches throughout the world.
The Cinterion-enabled Aera-CT improves the ability to rapidly detect heart arrhythmias during normal day-to-day activities and over long periods of time. Designed for ease-of-use and comfort, the discreet device is placed on the patient with as few as three electrodes.
Cinterion’s module enables secure and reliable communication of detailed diagnostic data via cellular networks and the Internet, providing patients and their physicians with 24/7 monitoring and improved detection and visibility of arrhythmia events. Authorized caregivers can securely view patient data at anytime, from anywhere in the world, to determine treatment approaches.
Cinterion’s high quality modules are engineered to meet rigorous M2M requirements for security, longevity and environmental extremes. They are Full Type Approved and pre-approved by global mobile network operators to help ensure a swift and cost effective time to market for OEMs and integrators.
For more information, please visit: www.tzmedical.com, www.cinterion.com